Interferon alpha2a | yeast; marketed in Mena region; new technology with improved yield; RCB, USP, DSP IPC/QC protocols available; PEGylated process available |
Interferon alpha2b | yeast; licensed to India; RCB, USP, DSP IPC/QC protocols available; PEGylated process available |
Hirudin | yeast; marketed in Mena region; new technology with improved yield available, MCB/WCB, USP, DSP, IPC/QC protocols available |
Bivalirudin | yeast; licensed to Egypt; RCB, USP, DSP IPC/QC protocols available |
Full length factor VIII | mammalian; MCB/WCB, USP, DSP IPC/QC protocols available |
Insulin | yeast; cell line and process as marketed in India; RCB, USP, DSP IPC/QC protocols available |
Detemir | yeast; RCB, USP protocols available; IPC/QC & DSP development time: approx. 6 months |
Liraglutide | yeast; RCB, USP protocols available; IPC/QC & DSP development time: approx. 6 months |
Lispro | yeast; proof-of-concept for expression achieved; cell line & process to be developed; development time: approx. 9 months |
Glargin | yeast; proof-of-concept for expression achieved; cell line & process to be developed; development time: approx. 9 months |
Teduglutide | yeast; cell line & process to be developed; development time: approx. 9 months |
Aspart | yeast; cell line & process to be developed; development time: approx. 9 months |
G‑CSF | E. coli; RCB, USP protocols available; IPC/QC & DSP development time: approx. 6 months |
hGrowth Hormone | yeast; RCB, USP protocols available, IPC/QC & DSP development time: approx. 6 months |
PTH | yeast; MCB/WCB, USP; DSP IPC/QC protocols available |
Follicle stimulating Hormone | mammalian; MCB/WCB, USP, DSP IPC/QC protocols available |
Staphylokinase | yeast; RCB, USP, DSP IPC/QC protocols available |
HSA | yeast; RCB, USP protocols available; IPC/QC & DSP development time: approx. 6 months |